1 active not recruiting. 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 1 | Active not recruiting 1 |
Follow Lbh589: new trials by email Literature Review of Lbh589 trials Research Report on Lbh589
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| CINC424A2X01B Rollover Protocol ruxolitinib, panobinostat - Primary Myelofibrosis, Polycythemia Vera | Phase 4 | Active not recruiting | Novartis Pharmaceuticals | 279 | 2015-03-05 | 2026-10-19 |
Bronchiolitis Obliterans Syndrome (1) · Graft vs Host Disease (1) · Leukemia, Myeloid, Acute (1) · Polycythemia Vera (1) · Primary Myelofibrosis (1) · Thalassemia (1)
Australia (1) · Belgium (1) · Bulgaria (1) · Canada (1) · Chile (1) · China (1) · France (1) · Germany (1) · Greece (1) · Hungary (1) · India (1) · Israel (1) · Italy (1) · Japan (1) · Lebanon (1)
2014 (1)